Mesenchymal stem cell secretions improve donor heart function following ex vivo cold storage
Author(s) -
Meijing Wang,
Liangliang Yan,
Qianzhen Li,
Yang Yang,
Mark W. Turrentine,
Keith L. March,
IWen Wang
Publication year - 2020
Publication title -
journal of thoracic and cardiovascular surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.458
H-Index - 192
eISSN - 1085-8687
pISSN - 0022-5223
DOI - 10.1016/j.jtcvs.2020.08.095
Subject(s) - mesenchymal stem cell , exosome , ex vivo , cold storage , cardioprotection , medicine , transplantation , microvesicles , reperfusion injury , ischemia , paracrine signalling , pharmacology , in vivo , chemistry , pathology , biology , microrna , receptor , biochemistry , microbiology and biotechnology , horticulture , gene
Heart transplantation is the gold standard of treatments for end-stage heart failure, but its use is limited by extreme shortage of donor organs. The time "window" between procurement and transplantation sets the stage for myocardial ischemia/reperfusion injury, which constrains the maximal storage time and lowers use of donor organs. Given mesenchymal stem cell (MSC)-derived paracrine protection, we aimed to evaluate the efficacy of MSC-conditioned medium (CM) and extracellular vesicles (EVs) when added to ex vivo preservation solution on ameliorating ischemia/reperfusion-induced myocardial damage in donor hearts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom